Physician profile
Tania Ramirez
NPI 1104593854
$528.25
in general payments reported to CMS, 2019-2025
12 companies · $14.58 in 2025
The $14.58 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $196 · 2024: $318 · 2025: $14.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $528.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $98.57 | 2023-2024 | |
| Glaxosmithkline, LLC. | $78.20 | 2023-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Lilly USA, LLC | $68.23 | 2023-2024 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $53.98 | 2024 | Cologuard Collection Kit |
| Shield Therapeutics INC | $48.84 | 2023-2024 | Accrufer |
| Novo Nordisk INC | $39.90 | 2024 | Rybelsus, Ozempic |
| Novartis Pharmaceuticals Corporation | $34.56 | 2023 | |
| Astellas Pharma US INC | $24.97 | 2024 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.47 | 2024 | Jardiance |
| Teva Pharmaceuticals USA, INC. | $23.64 | 2023 | Austedo Xr |
| Phathom Pharmaceuticals, INC. | $18.31 | 2024 | Voquezna |
| Boston Scientific Corporation | $14.58 | 2025 | General - Pain Management |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tania Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.